The Obesity Revolution
A new generation of obesity drugs is transforming patients’ lives, dividing medical experts, and spurring the biggest business battle in years. Known as GLP-1-based drugs, this medication class could have the medical and societal impact of blockbusters like Viagra, Lipitor, and Prozac. Like them, these weight-loss drugs have the potential to reshape the way we think of what it means to be sick and what it takes to be healthy.
Latest
STAT Plus: New weight loss drugs have proven their effectiveness. Now researchers want to know how to best use them
STAT Plus: Even as Wegovy rides high, interest surges in weight loss drugs that preserve muscle
STAT Plus: Our expensive obesity drugs are worth it, Novo Nordisk and Eli Lilly argue in raft of studies
STAT Plus: How one scientist’s determination made Novo Nordisk an obesity-drug powerhouse
GLP-1 drugs are transforming diabetes, obesity and more. Could a Nobel be next?
STAT Plus: The Ozempic revolution is rooted in the work of Svetlana Mojsov, yet she’s been edged out of the story
STAT Plus: New obesity drugs are in the works trying to out-blockbuster Wegovy and Mounjaro
All Coverage
